- €1.38bn
- €1.81bn
- €1.07bn
- 80
- 51
- 28
- 52
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 855 | 615 | 751 | 981 | 1,066 |
Cost of Revenue | |||||
Gross Profit | 292 | 225 | 257 | 354 | 377 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 766 | 568 | 643 | 879 | 940 |
Operating Profit | 89.5 | 47.7 | 108 | 102 | 126 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 85.2 | 42.3 | 103 | 96 | 111 |
Provision for Income Taxes | |||||
Net Income After Taxes | 67.6 | 34 | 92.9 | 63.9 | 73.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 67.7 | 41.8 | 82 | 55.1 | 72.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 67.7 | 41.8 | 82 | 55.1 | 72.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.22 | 0.714 | 1.71 | 1.37 | 1.54 |